Zimmer Biomet is one of the three most expensive stocks in the market right now, according to an Economic News Daily report.
Here are four notes:
1. The company has the high P/E ratio on Wall Street at 98.50. The P/E ratio is equal to a stock's market capitalization divided by its after-tax earnings over a 12-month period.
2. The stock, currently at $99.49, is up 12.08 percent from its 52-week low.
3. The stock trades at an average volume of 1.18 million shares.
4. Zimmer Biomet's key competitors include ConforMIS, LDR Holding and Globus Medical.